Salute e Benessere

Teva and mAbxience Expand Strategic Partnership to include an additional…

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration supports Teva's Pivot to Growth strategy and adds to the company's biosimilar portfolio Both companies reaffirm their shared commitment to making high-quality, affordable treatments accessible to patients worldwide TEL AVIV, ISRAEL and MADRID, Oct.03, 2024(GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a...
Nasdaq GlobeNewswire
03/10/2024

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring…

DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients into Cohort 3 /2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD).Cohort 2 enrolled 19 patients who received at least 1 dose of study drug (SYN-004 or Placebo randomized 2:1). Eighteen (18) patients received...
Nasdaq GlobeNewswire
03/10/2024

Recent clinical data confirms significantly improved predictive power of…

Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates The improvement has been achieved through iterative learning and the integration of advanced bioinformatics and machine learning techniquesIn the ongoing phase 2 trial with personalized cancer vaccine EVX-01, 79% of the AI-Immunology™ predicted vaccine targets triggered a tumor-specific immune response, a significant...
Nasdaq GlobeNewswire
03/10/2024

Virbac : Declaration of the number of shares and voting rights 09/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20248 390 660Gross total of voting...
Nasdaq GlobeNewswire
03/10/2024

Pioneering hospitals take major steps towards decarbonizing healthcare with…

Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower costAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following collaboration with customers worldwide to assess and mitigate their carbon footprints, while also enhancing patient...
Nasdaq GlobeNewswire
03/10/2024

Atomic Antibiotics Developed by Czech Scientists Counter Bacterial Resistance

A Frontal Attack with Manganese A Frontal Attack with Manganese In developing this antibiotic, the scientists drew on their expertise in graphene chemistry and atomic engineering, fields they have extensively studied in recent years. This time, they utilized a graphene derivative enriched with oxygen and nitrogen atoms, chemically incorporating manganese—a transition metal that is involved in metabolism, bone formation, blood sugar regulation and cellular protection against oxidative...
PR Newswire
03/10/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per October 1, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,534,358 shares, corresponding to 5.02% (previously 4.97%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
03/10/2024

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET…

"The CE mark of the NeuroLF system is another important milestone in the development of this dedicated brain PET system and represents a significant advance in the availability of brain PET imaging, allowing nuclear medicine physicians in Europe to offer a dedicated imaging modality to diagnose and monitor patients with brain related disorders", says Prof. Dr. med. Osama Sabri, Director and Chairman of the Department of Nuclear Medicine at the University of Leipzig Medical Center…
PR Newswire
03/10/2024

Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair…

Paul Sekhri, seasoned life sciences executive with decades of drug development and extensive business development experience, appointed Chair of the Board of Directors Paul Sekhri, seasoned life sciences executive with decades of drug development and extensive business development experience, appointed Chair of the Board of Directors EDINBURGH, ScotlandandLONDON,Oct. 3, 2024/PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical...
PR Newswire
03/10/2024

Veritas Genetic participates in a groundbreaking study highlighting the…

Key Findings of the Study Key Findings of the Study The study, published in the Journal of Personalized Medicine, evaluated women with a family history of breast cancer, demonstrating that PRS significantly improves the accuracy of individual risk prediction. This is particularly relevant for women who are non-carriers of pathogenic variants in susceptibility genes. For carriers of mutations in genes likeBRCA1andBRCA2, PRS offers a complementary approach that helps refine...
PR Newswire
03/10/2024

XRP Healthcare and Foventa Collaborate for Africa's Premier Lab Expo

This partnership aligns with XRP Healthcare's broader strategy to advance healthcare innovation, particularly in artificial intelligence (AI). The company recently established a dedicated AI team to pioneer advancements in healthcare AI, positioning itself at the forefront of AI integration in diagnostics, patient care, and medical research throughoutAfrica. In conjunction with the event, XRP Healthcare is set to unveil the much-anticipated fourth edition ofXRP Healthcare...
PR Newswire
03/10/2024

Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00…

Saint Herblain (France), October 3, 2024 – Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will host an investor day at the Lotte New York Palace Hotel in New York, NY on Thursday, October 10, 2024 at 10:00 AM ET (4:00 pm CET). The meeting will be conducted in a hybrid way – in person and webcast. To register,click here.The event will focus on Valneva's robust R&D pipeline of potentially first-, only-, or best-in-class vaccine...
Nasdaq GlobeNewswire
03/10/2024

IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create…

A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for Cancer Louvain-la-Neuve, Belgium , October 3, 2024– IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, is pleased to announce that the European Commission has approved the financing of the Accelerate.EU project launching on October 1, 2024. IBA's key role in this new project...
Nasdaq GlobeNewswire
03/10/2024

New data indicates use of 3D specimen tomosynthesis can improve breast cancer…

"The MOZART System with its tomosynthesis imaging technology gives us immediate and highly detailed 3D information, which allows us to make more precise surgical decisions," remarked Dr. Kothari. "Reducing repeat surgeries is a huge benefit for patients and healthcare systems." "The MOZART System with its tomosynthesis imaging technology gives us immediate and highly detailed 3D information, which allows us to make more precise surgical decisions," remarked Dr…
PR Newswire
03/10/2024

Kanazawa University research: Shedding light on how tissues grow with sharply…

Recent advances that have enabled the growth of tissue cultures into organoids and embryoids have heightened interest as to how tissue growth is controlled during the natural processes of embryo development. It is known that the diffusion of signaling molecules called morphogens directs patterned tissue growth but what has been harder to understand is how the gradient of morphogens from this diffusion can lead to sharply defined domains in the resulting tissue (Fig. 1). Now Satoshi Toda at…
PR Newswire
03/10/2024

Ipsen's IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market…

As per DelveInsight analysis, in 2023, the total diagnosed prevalent cases of primary biliary cholangitis in the 7MM were approximately 298K. These cases are projected to increase further during the forecast period (2024–2034). In 2023, the United States had the highest proportion of diagnosed prevalent cases of primary biliary cholangitis among the 7MM, comprising approximately 48% of the total cases. As per DelveInsight analysis, in 2023, the total diagnosed prevalent cases of primary…
PR Newswire
02/10/2024

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 09/30/2024100,093,87388,569,683For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] Patricia Sosa Navarro, Chief of Staff to the...
Nasdaq GlobeNewswire
02/10/2024

Certara Completes Acquisition of Chemaxon

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. Chemaxon develops leading scientific informatics software products used by the life sciences industry forin-silicoresearch. Certara develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties of large and small molecules...
Nasdaq GlobeNewswire
02/10/2024

Casino Group: Store disposals

Casino Group completes two wavesof store disposalsParis, 2 October 2024Following the agreements reached on 26 May 2023, Casino Group announces that it has sold its controlling 51% stake in 60 stores 1to Groupement les Mousquetaires on 30 September 2024. Groupement les Mousquetaires already holds a 49% stake in these stores from 30 September 2023. *** Following the agreements communicated on 22 June 2024, Casino Group announces the completion yesterday of the acquisition by...
Nasdaq GlobeNewswire
02/10/2024

Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the…

Download FREE PDF Brochure Of Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis - https://www.meticulousresearch.com/download-sample-report/cp_id=5864 Download FREE PDF Brochure Of Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis - https://www.meticulousresearch.com/download-sample-report/cp_id=5864 The growth of the regenerative medicine market is driven by the growing number of new regenerative medicine approvals, consistent advancements...
PR Newswire
02/10/2024

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV…

This collaboration marks a significant step in expanding access to life-saving treatments for heavily treatment-experienced patients with multi-drug-resistant HIV and offers a promising option for HIV prevention in underserved regions. Lenacapavir is a breakthrough HIV-1 capsid inhibitor that works with other antiretroviral drugs to treat multi-drug-resistant HIV-1 infections. It has a unique ability to target multiple stages of the HIV lifecycle, making it highly effective for patients with…
PR Newswire
02/10/2024

Norgine Announces Appointment of New CEO Janneke van der Kamp

Peter Stein, Chairman of Norgine said: "On behalf of the Norgine Board of Directors and shareholders, we are excited to welcome Janneke to lead Norgine. She is a world class and proven strategic leader with extensive experience in the pharmaceutical industry, leading organisations and launching innovative products to transform patient outcomes. With Janneke's appointment, we have attracted the ideal leader for the next phase of Norgine's exciting growth. Janneke brings to Norgine a deep…
PR Newswire
02/10/2024

Haier Smart Home Successfully Completes Acquisition of Carrier Commercial…

"We are thrilled to welcome the 4,000+ Carrier Commercial Refrigeration employees into the Haier family," said Li Huagang, Chairman and CEO of Haier Smart Home. "This transaction not only broadens our product portfolio but also provides a unique opportunity to create a better and more sustainable solution provider from industrial & food retail refrigeration to cold storage. The well-known brands such as Carrier Commercial Refrigeration, Profroid, Celsior, and Green &…
PR Newswire
02/10/2024

Recursion Announces FDA Clearance of Investigational New Drug Application for…

First program to combine Recursion's end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 monthsPlan to initiate dosing of Phase 1/2 in Q4 2024 to evaluate REC-1245 in a biomarker enriched patient population, including patients with solid tumors and lymphomaSALT LAKE CITY, Oct.02, 2024(GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize...
Nasdaq GlobeNewswire
02/10/2024
Altri  Comunicati